MADISON — By the time today’s 30-year-olds are senior citizens, Alzheimer’s disease and dementia will have taken an overwhelming financial toll on the United States and other countries around the world, according to Dr. Eric Reiman.
A professor of psychiatry at the University of Arizona and one of the nation’s leaders in Alzheimer’s research, Reiman will keynote the University of Wisconsin-Madison’s inaugural Alzheimer Research Day.
Reiman’s talk will focus on the great progress that’s being made in the study of Alzheimer’s disease and substantial progress in the promising but unproven treatments that strike at the heart of the disease.
“Now is the time to launch a new era in Alzheimer’s prevention research,” said Reiman. “Up until now, our biggest roadblock has been the time it takes to evaluate a prevention therapy. We need the scientific means, the regulatory approval pathway, new public policies, and new ways of working together to rapidly evaluate the range of promising therapies and find out which ones work as soon as possible.”
The inaugural Alzheimer Research Day takes place Friday, March 14 at the Wisconsin Institutes for Discovery in the H.F. Deluca Forum at 1 p.m.
